Supplemental material
Journal of Medical Economics
Volume 26, 2023 - Issue 1
Open access
1,805
Views
2
CrossRef citations to date
0
Altmetric
Cardiovascular
Frequency and clinicoeconomic impact of delays to definitive diagnosis of obstructive hypertrophic cardiomyopathy in the United States
Srihari S. Naidua Westchester Medical Center, Westchester Medical Center Health Network, Valhalla, NY, USA;b New York Medical College, Valhalla, NY, USACorrespondence[email protected]
https://orcid.org/0000-0003-4073-5143
Megan B. Suttonc MyoKardia, Inc., a wholly owned subsidiary of Bristol Myers Squibb, Brisbane, CA, USA
, Wei Gaod Analysis Group, Inc., Boston, MA, USA
https://orcid.org/0000-0002-4088-3210
Jennifer T. Finec MyoKardia, Inc., a wholly owned subsidiary of Bristol Myers Squibb, Brisbane, CA, USA
, Jipan Xiee Analysis Group, Inc., Los Angeles, CA, USA
https://orcid.org/0000-0001-5937-0936
Nihar R. Desaif Yale University School of Medicine, New Haven, CT, USA
https://orcid.org/0000-0003-2384-2545
Anjali T. Owensg Center for Inherited Cardiovascular Disease, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA
https://orcid.org/0000-0002-9669-8495
Pages 682-690
|
Received 13 Feb 2023, Accepted 27 Apr 2023, Published online: 11 May 2023
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.